Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

2002435 citationsJournal Article

Authors

Thomas J. Walsh · National Cancer Institute

Irja Lutsar · Pfizer (United States)

Timothy Driscoll · Duke University

B. Dupont · Institut Pasteur

Maureen Roden · National Institutes of Health

PARVIS GHAHRAMANI · Pfizer (United States)

Michael R. Hodges ·

Abstract

These data support the use of voriconazole for treatment of invasive fungal infections in pediatric patients who are intolerant of or refractory to conventional antifungal therapy.

Topics & Keywords

Antifungal resistance and susceptibility Fungal Infections and Studies Ocular Infections and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Pediatric Infectious Disease Journal

Volume 21, Issue 3, pp. 240-248

DOI: 10.1097/00006454-200203000-00015

Field-Weighted Citation Impact: 18.58